Burning Rock Biotech (BNR) EPS (Weighted Average and Diluted): 2021-2025
Historic EPS (Weighted Average and Diluted) for Burning Rock Biotech (BNR) over the last 4 years, with Mar 2025 value amounting to -$0.14.
- Burning Rock Biotech's EPS (Weighted Average and Diluted) rose 89.84% to -$0.14 in Q1 2025 from the same period last year, while for Mar 2025 it was $13.86, marking a year-over-year decrease of 51.61%. This contributed to the annual value of -$3.83 for FY2024, which is 49.54% up from last year.
- As of Q1 2025, Burning Rock Biotech's EPS (Weighted Average and Diluted) stood at -$0.14, which was up 78.96% from -$0.69 recorded in Q4 2024.
- Burning Rock Biotech's 5-year EPS (Weighted Average and Diluted) high stood at $28,954 for Q1 2021, and its period low was -$25,907 during Q1 2022.
- In the last 3 years, Burning Rock Biotech's EPS (Weighted Average and Diluted) had a median value of -$0.69 in 2024 and averaged $4.69.
- Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first skyrocketed by 1,790.05% in 2022, then slumped by 350.49% in 2024.
- Burning Rock Biotech's EPS (Weighted Average and Diluted) (Quarterly) stood at -$2.99 in 2021, then spiked by 1,790.05% to $50.48 in 2022, then crashed by 33.37% to $33.64 in 2023, then tumbled by 102.04% to -$0.69 in 2024, then surged by 89.84% to -$0.14 in 2025.
- Its EPS (Weighted Average and Diluted) was -$0.14 in Q1 2025, compared to -$0.69 in Q4 2024 and $15.95 in Q3 2024.